Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.

Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S.

Bone Marrow Transplant. 2019 Jan 21. doi: 10.1038/s41409-019-0440-5. [Epub ahead of print]

PMID:
30664726
2.

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-Up Analysis.

Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V.

Biol Blood Marrow Transplant. 2019 Jan 10. pii: S1083-8791(19)30015-1. doi: 10.1016/j.bbmt.2019.01.007. [Epub ahead of print]

PMID:
30639823
3.

Long-term outcome of kidney transplantation in AL amyloidosis.

Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A.

Kidney Int. 2019 Feb;95(2):405-411. doi: 10.1016/j.kint.2018.09.021. Epub 2018 Dec 21.

PMID:
30580886
4.

Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis.

Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1823-1827. doi: 10.1016/j.bbmt.2018.06.018. Epub 2018 Jun 20.

PMID:
29933072
5.

High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.

White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V.

Bone Marrow Transplant. 2018 Dec;53(12):1593-1595. doi: 10.1038/s41409-018-0242-1. Epub 2018 Jun 8. No abstract available.

PMID:
29884854
6.

Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients.

Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K.

Transfus Apher Sci. 2018 Jun;57(3):411-415. doi: 10.1016/j.transci.2018.04.025. Epub 2018 Apr 26.

PMID:
29731423
7.

High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.

Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V.

Biol Blood Marrow Transplant. 2018 Jan;24(1):127-132. doi: 10.1016/j.bbmt.2017.08.031. Epub 2017 Sep 1.

8.

Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation.

Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V.

Blood. 2017 Sep 14;130(11):1383-1386. doi: 10.1182/blood-2017-06-788729. Epub 2017 Jul 11. No abstract available.

9.

Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial.

Sanchorawala V, Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC.

Blood. 2016 Aug 25;128(8):1059-62. doi: 10.1182/blood-2016-04-710822. Epub 2016 Jul 5.

10.

The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation.

Dittus C, Uwumugambi N, Sun F, Sloan JM, Sanchorawala V.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1729-1732. doi: 10.1016/j.bbmt.2016.05.027. Epub 2016 Jun 11.

11.

Surgical Management of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Associated With Light-Chain Deposition Disease.

Muñoz-Largacha JA, O'Hara CJ, Sloan JM, Fernando HC, Litle VR.

Ann Thorac Surg. 2016 Jun;101(6):e207-10. doi: 10.1016/j.athoracsur.2015.10.089.

PMID:
27211983
12.

Clinical presentation and treatment responses in IgM-related AL amyloidosis.

Sissoko M, Sanchorawala V, Seldin D, Sworder B, Angelino K, Broce M, Berk J, Sloan JM.

Amyloid. 2015;22(4):229-35. doi: 10.3109/13506129.2015.1092433. Epub 2015 Oct 21.

PMID:
26488936
13.

Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis.

Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM.

Haematologica. 2016 Jan;101(1):86-90. doi: 10.3324/haematol.2015.133900. Epub 2015 Oct 9.

14.

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.

Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC.

Blood. 2015 Nov 12;126(20):2345-7. doi: 10.1182/blood-2015-08-662726. Epub 2015 Oct 6. No abstract available.

15.

Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.

Sanchorawala V, Brauneis D, Shelton AC, Lo S, Sun F, Sloan JM, Quillen K, Seldin DC.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1445-51. doi: 10.1016/j.bbmt.2015.04.001. Epub 2015 Apr 6.

16.

Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.

Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K.

Amyloid. 2014 Sep;21(3):149-53. doi: 10.3109/13506129.2014.900486. Epub 2014 Apr 29.

PMID:
24779777
17.

Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis.

von Keudell G, Sanchorawala V, O'Hara C, C Seldin D, Sloan JM.

Amyloid. 2014 Jun;21(2):124-7. doi: 10.3109/13506129.2013.854205. Epub 2014 Jan 29.

PMID:
24471777
18.

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center.

Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V.

Blood. 2012 Nov 22;120(22):4445-6. doi: 10.1182/blood-2012-09-457341. No abstract available.

19.

Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial.

Sanchorawala V, Patel JM, Sloan JM, Shelton AC, Zeldis JB, Seldin DC.

Haematologica. 2013 May;98(5):789-92. doi: 10.3324/haematol.2012.075192. Epub 2012 Nov 9.

20.

Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review.

Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V.

Amyloid. 2012 Sep;19(3):156-60. doi: 10.3109/13506129.2012.694825. Epub 2012 Jun 11. Review.

PMID:
22680044

Supplemental Content

Loading ...
Support Center